Increased expression of TIGIT on NK-cells in the peripheral blood has been reported in patients with myelodysplastic syndrome (230), high risk non-muscle invasive bladder cancer (231) and gastrointestinal cancer (gastric and colon cancer) (171). This evidence concerns the gene TIGIT and malignant colon neoplasm.